Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robyn N. Jordan
Observed names:
R. Jordan,
Robyn N Jordan
Institutions:
Johns Hopkins University,
Johns Hopkins Medicine,
Johns Hopkins Hospital
Observed institutions:
Johns Hopkins University,
University of California, San Francisco,
Johns Hopkins Medicine,
Johns Hopkins Hospital
ORCID:
0000-0002-5540-5019
Observed ORCID:
0000-0002-5540-5019
OpenAlex ID:
A5010109891
Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients
2024
·
S.S. Yom
, J. Harris
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
75
Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004
2022
·
L.K. Mell
, P. Torres-Saavedra
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
50
Perceptions of and Barriers to Colorectal Cancer Screening Uptake in Underserved Baltimore and Eastern Shore Populations
2026
·
Robyn N. Jordan
, Celia Marion
, et al.
·
Journal of Cancer Education
PDF
Federal housing assistance, cancer care, and overall survival among older adults with prostate cancer
2026
·
Katherine L Chen
, Taylor K Craig
, et al.
·
JNCI Journal of the National Cancer Institute
Abstract B060: Community-informed development of educational materials to improve colorectal cancer screening uptake in underserved Baltimore populations
2025
·
Celia Marion
, Robyn N. Jordan
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)
2024
·
J. Bauman
, J. Harris
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer with Exploratory Biomarker Correlatives
2024
·
R.L. Ferris
, P. Torres-Saavedra
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
167: Comparison of Midgut and Pancreatic Neuroendocrine Tumors at a Tertiary Medical Center
2022
·
Robyn N. Jordan
, Dorian Mendoza
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
8
Citation count:
125
H-index:
2
I10-index:
2
Year
Topic
Type
